Leadership teams representing Canada’s five biomanufacturing and life sciences research hubs came together to set the stage for a new wave of biomedical innovation in Canada.
The goal of the session was to deepen collaboration across the five research hubs as they work to enhance Canada’s pandemic preparedness and biomanufacturing capacity, and to shape the hubs’ collective strategy for addressing the most pressing health challenges facing Canadians.
“We are in this together and supporting one another to transform Canada’s bio-economy and develop next-generation medicines that will benefit all Canadians. CIEBH is focused on collective success and is actively working to leverage existing Canadian strengths, build on our collaborative research efforts and increase partnerships,” said Dr. Michelle Wong, executive director of Canada’s Immuno-Engineering and Biomanufacturing Hub and senior director, research, UBC’s Faculty of Medicine.
In a symbolic gesture, participants wore Canada flag pins to demonstrate their interconnectedness and shared vision to enhance the country’s ability to respond to emerging health threats. They underscored their common goal of strengthening the national life sciences and biomanufacturing sector and their commitment to a new way of working—as one unified national ecosystem—to ultimately create meaningful results for Canadians. The full-day meeting at the University of Toronto campus included team members from each of the five hubs:
